1.In vitro study on bone resorption of odontogenic cysts and ameloblastomas.
Chinese Journal of Stomatology 2005;40(3):233-236
OBJECTIVETo investigate the effect of bone resorption by odontogenic cysts and ameloblastomas in vitro.
METHODSFragments of odontogenic cysts (14 odontogenic keratocysts, 6 inflamed odontogenic keratocysts, 5 dentigerous cysts) and ameloblastomas (n = 7) were incubated in vitro for 24 h. The supernatant was then removed into the culture system of SD rat calvaria. After incubation (48 h), the calcium contents of the media were measured by atom spectrophotometer. The supernatant of odontogenic cysts and ameloblastomas was measured for the bone resorption related factors such as IL-6, TNF-alpha, PGE(2), bone Gla-containing protein (BGP) and calcitonin (CT) by a radioimmunoassay system.
RESULTSThe calcium released in the calvaria culture media by all the odontogenic lesions was significantly higher than that in the blank controls (P < 0.01). The inflamed odontogenic keratocyst group had a significantly higher calcium concentration than odontogenic keratocyst and ameloblastoma groups (P < 0.05). In addition, the concentration of IL-6, TNF-alpha, PGE(2) and CT in the culture media of all odontogenic lesions were significantly higher than that of the blank controls (P < 0.05). IL-6 concentration in the inflamed and non-inflamed odontogenic keratocyst groups were significantly higher than that of ameloblastoma group (P < 0.05). CT concentration in the inflamed odontogenic keratocyst was significantly higher than those of odontogenic keratocyst and dentigerous cyst groups (P < 0.05). Correlation and regression analysis showed that IL-6 was significantly correlated with the calcium content (P < 0.01).
CONCLUSIONSThe odontogenic lesions could promote bone resorption in vitro and it is likely to be related to some of the cytokines secreted by the lesions.
Ameloblastoma ; metabolism ; physiopathology ; Animals ; Bone Resorption ; Humans ; In Vitro Techniques ; Odontogenic Cysts ; metabolism ; physiopathology ; Rats ; Rats, Sprague-Dawley
2.Fatigue damage and repair in bone.
Chunqiu ZHANG ; Dankai WU ; Yuxiang GUO ; Tongtong GUO ; Xinghua ZHU
Journal of Biomedical Engineering 2003;20(1):180-186
Bone is a load-bearing organ in human body. Fatigue damage occurs readily at the modest loads to which bone is subjected during its habitual physiological usage. Even bone fracture may occur during vigorous activity. The nature of fatigue damage is that in bone there are very fine microcracks which are smaller than typical microcracks, and may occur at the level of hydroxyapatite crystals. But bone can repair microdamage by bone remodeling. Osteocytes play an important role of signaling during bone remodeling. Some researchers attempted to describe the process of bone fatigue damage and repair by mathematic, mechanical models in order to understand it well and to apply it well in clinical practice.
Animals
;
Bone Remodeling
;
physiology
;
Bone Resorption
;
pathology
;
physiopathology
;
Bone and Bones
;
cytology
;
injuries
;
physiology
;
Fractures, Stress
;
pathology
;
physiopathology
;
Humans
;
Models, Biological
;
Stress, Mechanical
3.Changes in biochemical bone markers during pregnancy and puerperium.
Byung Koo YOON ; Jeong Won LEE ; Doo Seok CHOI ; Cheong Rae ROH ; Je Ho LEE
Journal of Korean Medical Science 2000;15(2):189-193
To elucidate the changes in bone turnover during pregnancy and puerperium, we measured serially the levels of serum osteocalcin and urine deoxypyridinoline (Dpy) as markers of bone formation and bone resorption, respectively, in 22 healthy women with normal pregnancy. Nineteen non-pregnant women served as control. The Dpy levels increased significantly at 16 weeks of pregnancy and remained elevated thereafter. The levels of osteocalcin, however, were significantly decreased at 16 weeks of pregnancy and elevated later at 6 weeks postpartum. Bone turnover ratio (Dpy/osteocalcin) continued to rise during pregnancy, but returned to control levels 6 weeks after delivery. Dpy levels and bone turnover ratio during puerperium tended to be higher in 17 breast-feeding women than those of 5 exclusive bottle-feeders. In conclusion, bone resorption begins to increase from the second trimester of pregnancy and calcium release from bone tissue might play a major role in calcium homeostasis during the whole period of pregnancy as well as during lactation.
Adult
;
Amino Acids/urine
;
Analysis of Variance
;
Biological Markers*
;
Bone Resorption/physiopathology*
;
Calcium/metabolism
;
Female
;
Human
;
Lactation/physiology
;
Osteocalcin/blood
;
Osteoporosis/physiopathology*
;
Pregnancy
;
Pregnancy Complications/physiopathology*
;
Puerperium/physiology*
4.Progress of study on prevention and treatment of osteoporosis by compound Gushukang.
Xi-juan WANG ; Ri-xin LIANG ; Lu ZHAO
Chinese Journal of Integrated Traditional and Western Medicine 2007;27(3):282-285
Gushukang is a compound Chinese herbal preparation. Pharmacological studies indicated that Gushukang can increase bone density, inhibit bone resorption, promote bone formation, and restore bone microstructure, as well as improve bone biomechanical parameters and promote healing of bone fracture. Clinical observations demonstrated that it has favorable efficacy in preventing and treating osteoporosis.
Bone Density
;
drug effects
;
Bone Resorption
;
prevention & control
;
Drugs, Chinese Herbal
;
therapeutic use
;
Humans
;
Osteogenesis
;
drug effects
;
Osteoporosis
;
drug therapy
;
physiopathology
;
Phytotherapy
5.Comparison of effects of Wujia Bugu decoction) and alendronate sodium on protection the bone loss of hindlimb unloaded rats.
Qian FU ; Su-Min HU ; Jia-Jia YANG ; Xi-Juan HAO ; Bin ZHU ; Qian WANG ; Zheng-Rong WU ; Jin LI
China Journal of Orthopaedics and Traumatology 2010;23(7):524-528
OBJECTIVETo compare the effects of Wujia Bugu decoction and Alendronate sodium on protecting bone and muscle loss of hindlimb unloaded rats lasting three weeks.
METHODSMarch to May, 2009, 40 male Wistar rats with age of 6-week, were randomized divided to four groups (10 rats in each group): hindlimb unloaded group treated with Chinese medicine (HUC), hindlimb unloaded group treated with alendronate sodium (HUA), control group (CON), as well as hindlimb unloaded group (HU). During the experiment, rats of HUC was given Wujia Bugu decoction (including the Ciwujia, Shudihuang, Huainiuxi, Muli, etc. with the concentration of 0.704 g/ml) 10 ml/kg weight once a day, HUA was given quantitative alendronate sodium slice dissolve suspension (0.9 mg/ml) once a week. CON and HU were given double-distilled water. The experiment lasted 4 weeks,from the second to the forth week, rats in HU, HUC, HUA were hindlimb unloaded. All rats were sacrificed at the fourth weekend, the content of Ca, P and the activation of ALP in serum, Bone mineral density (BMD) of humerus and femurs, Biomechanical property of tibia and humerus, as well as the weight index of biceps and sural muscles were measured.
RESULTSCompared with CON, serum Ca of HU was significantly increased (P < 0.05), BMD, mechanical properties, muscle index of hindlimb were significantly reduce (P < 0.01), the serum Ca of HUA significantly increased (P < 0.05). Serum ALP of HUC was significantly higher than other three groups (P < 0.01). Compared with HU, femoral BMD of HUC and HUA significantly increased, tibial maximum load, maximum deflection and elastic load had increased tendency; calf muscle atrophy of HUC and HUA was alleviate 50% and 12.5% respectively (P > 0.05), humeral BMD had no significant difference, while the maximum deflection (P < 0.01) and elastic deflection (P < 0.05) in humerus of HUA were significantly lower.
CONCLUSIONHerbal prescription and alendronate sodium can effectively protect the bone and muscle loss of hindlimb unloaded rats, improve its mechanical structure. Herbal prescription has advantages of relieving mechanical properties change. The effects of Wujia Bugu decoction and alendronate sodium are similar in treating space weightlessness bone loss.
Alendronate ; administration & dosage ; Animals ; Bone Density ; drug effects ; Bone Resorption ; drug therapy ; physiopathology ; Disease Models, Animal ; Drugs, Chinese Herbal ; administration & dosage ; Femur ; drug effects ; physiopathology ; Hindlimb Suspension ; Humans ; Humerus ; drug effects ; physiopathology ; Male ; Random Allocation ; Rats ; Rats, Wistar
6.Research on effect of Sargentodoxae caulis on activity of osteoclasts and proliferation differentiation of osteoblasts.
Li-zhen CHEN ; Ying ZHOU ; Jun-fei HUANG ; Xue ZHANG ; Ting-ting FENG
China Journal of Chinese Materia Medica 2015;40(22):4463-4468
Through morphological observation, HE staining, TRAP staining and toluidine blue staining of bone resorption pits to identify osteoclasts which obtained by 1α, 25-(OH)2 VitD3 inducing rabbit bone marrow cells. Three indicators-TRAP staining, TRAP enzyme activity detecting and the number and area of bone resorption pits were adapted to detect the effect of Sargentodoxae caulis on the activity of osteoclasts. Culturing MC3T3-E1 Subclong 14 cells and detecting the effect of S. caulis on differentiation and proliferation of them by MTT and detecting the alkaline phosphatase in cells. The results show that all of the low, middle and high doses of water and alcohol extracts of S. caulis have significant inhibition on osteoclast differentiation and bone resorption ability in a dose-dependent manner. The low and middle doses of water and alcohol extracts of S. caulis can stimulate differentiation and proliferation of MC3T3-ElSubclone 14 cells, which indicates S. caulis can prevent osteoporosis and the function could be achieved by inhibiting osteoclast activity and promoting the proliferation and differentiation of osteoblasts.
Animals
;
Bone Resorption
;
drug therapy
;
physiopathology
;
Cell Differentiation
;
drug effects
;
Cell Proliferation
;
drug effects
;
Cells, Cultured
;
Drugs, Chinese Herbal
;
pharmacology
;
Humans
;
Mice
;
Osteoclasts
;
cytology
;
drug effects
;
Rabbits
7.Morphometry of osteoclasts in experimental fracture healing of rabbits.
Jiaqi WU ; Yuanying WU ; Yiwei JIANG ; Hongzhuan LI ; Xiaogang ZHANG ; Tianfu YANG
Journal of Biomedical Engineering 2007;24(4):889-893
This study was designed to investigate the effects of some Traditional Chinese Medicine (TCM) agents on bone resorption and morphometric features of osteoclasts as well as their relationships. TCM ShengGuZaiZaoSan and XianLingGuBao, were used to treat the experimental fracture. Thirty 6-month-old Chinchilla rabbits were used for the establishment of animal models each with a 3 mm bone defect in the middle of left radius as well as of right radius. These models were divided randomly into 3 groups : ShengGuZaiZaoSan Group (Group A), XianLingGuBao groups (Group B) and control-group (Group C). Every group was further divided into 2 subgroups: a former sacrificed group (14 days after operation) and a latter sacrificed group (31 days after operation). After the rabbits being killed, the samples of their undecalcified calli were subjected to the morphometry study of bone resorption and osteoclasts. Group A had more bone resorption, compared with Group B and C. Both Groups A and B exhibited some changed morphometric features of osteoclasts as compared with Group C (P < 0.05). Simple correlation analysis indicated that bone resorption is mainly correlated with osteoclast numbers, and that in individual group, bone resorption is correlated with osteoclast form factor, area and mean photodensity (P < 0.05). These allow us to conclude that ShengGuZaiZaoSan can increase bone resorption and accelerate bone remodeling by increasing osteoclast numbers at the former stage and can enhance osteoclast function at the latter stage. These changes are beneficial to fracture healing.
Animals
;
Bone Remodeling
;
drug effects
;
Bone Resorption
;
physiopathology
;
Drugs, Chinese Herbal
;
pharmacology
;
therapeutic use
;
Female
;
Fracture Healing
;
drug effects
;
physiology
;
Male
;
Osteoclasts
;
drug effects
;
pathology
;
Phytotherapy
;
Rabbits
;
Radius Fractures
;
drug therapy
;
pathology
;
physiopathology
;
Random Allocation
8.Benefit period using alendronate to increase bone mineral density in women with osteoporosis?
Ferda OZDEMIR ; Meliha RODOPLU
Chinese Medical Journal 2005;118(5):383-390
BACKGROUNDAlendronate, a nitrogen-containing bisphosphonate is a specific inhibitor of bone resorption and now in the forefront of treatment of osteoporosis. In this study, we reported a significant increase in bone mineral density (BMD) of the spine and the hip in postmenopausal women taking alendronate at 10 mg/d for 1, 2 and 3 years.
METHODSParticipants had received daily, oral, 10 mg dose of alendronate for one to three years and placed into one of three groups according to alendronate treatment duration: 41 women received alendronate for 1 year (group I), 46 received alendronate for 2 years (group II), and 30 received alendronate for 3 years (group III). Measurements of bone density had been made by dual energy X-ray absorbtiometry once each year.
RESULTSThe differences in L2-L4, L2, L4, femoral neck and trochanter BMD values before and after treatment for first group were significantly different. In second group, significant differences between initial and after treatment were found at the other sites except at the Ward's triangle. In the third group, only a significant increase in the L2-L4, L2, L3, L4, trochanter BMD values between before treatment and at the end of third year was found. Comparisons between groups were performed with Student's t test. ANOVA was used to test the age, menopause age, menopause duration and initial BMD values between the three groups. Calculated P values of less than 0.05 were considered statistically significant.
CONCLUSIONSAlendronate had increased BMD significantly at the spine and hip in postmenopausal women over three years. Increases of BMD in third group were significant during the first and second years. However, continued therapy with alendronate had been required to maintain the gain in BMD over the third year.
Absorptiometry, Photon ; Adult ; Aged ; Alendronate ; therapeutic use ; Analysis of Variance ; Bone Density ; drug effects ; Bone Resorption ; prevention & control ; Female ; Hip ; physiopathology ; Humans ; Middle Aged ; Osteoporosis, Postmenopausal ; drug therapy ; Spine ; physiopathology
9.Effect of puncturing shenshu point on the femoral biomechanical properties in senescence accelerated mouse prone 6.
Xue-Zhu ZHANG ; Ying-Mei PENG ; Jian-Chun YU
Chinese Journal of Integrated Traditional and Western Medicine 2008;28(6):518-521
OBJECTIVETo explore the mechanisms of puncturing Shenshu point in improving osteoporosis.
METHODSSerum levels of testosterone (T) and osteocalcin (BGP) in senescence accelerated mouse prone 6 (SAMP6, test animals) and senescence accelerated mouse resistant 1 (SAMR1, for control) were determined by radioimmunoassay and their femoral biomechanical properties were determined with three-point bending test before and after puncturing to observe the effect of puncturing on the femoral biomechanical properties and bone mineral contents.
RESULTSCompared with the SAMR1 control group, the serum level of T (20.91 +/- 3.41 nmol/L) decreased (11.09 +/- 1.48 nmol/L in SAMP6 mouse), BGP (6.7 +/- 2.07 microg/L) increased (12.29 +/- 2.29 microg/L in SAMP6 mouse), femoral bending strength lowered and fragility increased. These changes were all improved to some extent or normalized, serum T level 15.05 +/- 2.63 nmol/L and BGP 8.88 +/- 1.85 microg/L after needling at Shenshu point showed significant difference when compared with those in SAMP6.
CONCLUSIONPuncturing Shenshu point could effectively prevent the bone loss in SAMP6 mice, increase their bone strength, the therapeutic effect is partly by way of promoting the secretion of sex hormone, improving bone metabolism, suppressing bone transformation rate and increasing bone minerals.
Acupuncture Points ; Aging ; Animals ; Biomechanical Phenomena ; Body Weight ; Bone Resorption ; Calcium ; metabolism ; Femur ; metabolism ; physiology ; physiopathology ; Male ; Mice ; Minerals ; metabolism ; Osteocalcin ; blood ; Osteoporosis ; blood ; metabolism ; physiopathology ; prevention & control ; Punctures ; methods ; Testosterone ; blood
10.Ischemic Stroke in Rats Enhances Bone Resorption in Vitro.
Myung Eun CHUNG ; Jong In LEE ; Sun IM ; Joo Hyun PARK
Journal of Korean Medical Science 2012;27(1):84-88
We hypothesized that the formation and differentialtion of osteoclasts are accelerated and the potential of bone resorption is increased in the hemiplegic bone marrow in the early stage of stroke. We randomly divided white female Sprague-Dawley (SD) rats (n = 30) into two groups, stroke (n = 15) and sham group (n = 15). On the 7th day after stroke, after cutting away the epiphyses of the femurs and tibias, diaphyseal channels were flushed using alpha-minimum essential medium (alpha-MEM) and bone marrow cells were collected. Bone marrow stem cells, which were extracted from the femur and tibia, were cultured on the 7th day after middle cerebral artery occlusion. We then estimated the ratio of non-adherent cells to total bone marrow cells that included osteoclast precursor cells. After culturing these cells separately, cells that tested positive on the tartrate resistant acid phosphatase (TRAP) were counted and bone resorption was evaluated by using the OAAS(TM) plate. In comparison to the control group, the stroke group showed a higher increase of non-adherent cells in the hemiplegic side bone marrow. In addition, after the primary culture, the stroke group showed an increased number of TRAP positive cells and a higher degree of bone resorption estimated by OAAS(TM) plate. As a result, osteoclastogenesis and osteoclast differentiation are accelerated and the potential of bone resorption is increased in the hemiplegic bone marrow and these changes are detected as early as within the first week after middle cerebral artery occlusion in SD rats.
Animals
;
Bone Marrow Cells/cytology/drug effects
;
Bone Resorption/*physiopathology
;
Cell Differentiation
;
Cell Separation
;
Cells, Cultured
;
Female
;
Femur/cytology
;
Osteoclasts/cytology
;
Rats
;
Rats, Sprague-Dawley
;
Stem Cells/cytology/metabolism
;
Stroke/*metabolism/pathology
;
Tartrates/pharmacology
;
Tibia/cytology